Overview of FDA Drug Approval and Labeling.

Clarridge, Katherine E; Chin, Stacy J; Stone, Kelly D

Clarridge, Katherine E; Chin, Stacy J; Stone, Kelly D.

Afiliación

Clarridge KE; Division of Pulmonology, Allergy, and Critical Care, Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Md. Electronic address: Katherine.Clarridge@fda.hhs.gov.
Chin SJ; Division of Pulmonology, Allergy, and Critical Care, Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Md.
Stone KD; Division of Pulmonology, Allergy, and Critical Care, Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Md.

J Allergy Clin Immunol Pract ; 10(12): 3051-3056, 2022 12.

Article en En | MEDLINE | ID: mdl-36496207

Asunto(s)

Aprobación de Drogas; Uso Fuera de lo Indicado; Estados Unidos; Humanos; United States Food and Drug Administration; Etiquetado de Medicamentos; Etiquetado de Productos

Palabras clave

Drug; Drug regulation

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Aprobación de Drogas / Uso Fuera de lo Indicado Tipo de estudio: Risk_factors_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: J Allergy Clin Immunol Pract Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google